Drug Interactions
Active Resources: 20
-
Learning Objectives:
- Summarize the evidence for long-acting injectable HIV treatment and prevention
Type: Online and Self-Paced LearningPublish Date: 11/12/2021 -
Training slides review potential ARV drug-drug interactions and identify resources for the evaluation of drug-drug interactions.
Type: Training MaterialsPublish Date: 9/22/2021 -
Objectives:
Type: Training MaterialsPublish Date: 8/13/2021 -
Dr. Adrienne E Shapiro discusses highlights from the 2021 IAS Conference.
Type: Training MaterialsPublish Date: 8/13/2021 -
Learning Objectives:
- Recall processes and data from long-acting antiretroviral clinical trials
- Discuss why patients may desire long-acting antiretroviral therapy
Type: Training MaterialsPublish Date: 7/15/2021 -
This quick guide for clinicians discusses the drug interactions between Glecaprevir/Pibrentasvir (Mavyret™)
Type: Articles, Reports, and ManualsPublish Date: 7/14/2021 -
This quick guide for clinicians discusses the drug interactions between Elbasvir/Grazoprevir (Zepatier™)
Type: Articles, Reports, and ManualsPublish Date: 7/14/2021 -
Recommended management strategies for HIV patients experiencing virologic failure (VF) while taking antiretroviral therapy (ART).
Type: Training MaterialsPublish Date: 6/10/2021 -
Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of
Type: GuidelinesPublish Date: 6/3/2021Review Date: 7/5/2021 -
Archived webinar.
Type: Training MaterialsPublish Date: 3/3/2021 -
Hepatitis C Online is a free educational website from the University of Washington National Hepatitis Training Center. This project is funded by the Centers for D
Type: Online and Self-Paced LearningPublish Date: 1/15/2021 -
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention.
Type: Online and Self-Paced LearningPublish Date: 9/14/2020Review Date: 9/8/2021 -
Three sets of training slides covering what providers treating people with HIV should know about COVID-19.
Type: Training MaterialsPublish Date: 4/9/2020 -
Training slides cover HHS recommendations for treatment of transgender people with HIV.
Type: Training MaterialsPublish Date: 1/31/2020 -
This training slide set covers aging-related concerns for people with HIV, including management of ART.
Type: Training MaterialsPublish Date: 1/31/2020 -
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.
Type: Online and Self-Paced LearningPublish Date: 12/4/2019 -
A collection of clinical guides regarding drug interactions of hepatitis C virus (HCV) direct-acting antivirals (DAAs) with other common primary care medications and HIV antiretrovirals.
Type: Clinical Reference ToolsPublish Date: 11/1/2019 -
This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.
Type: Clinical Reference ToolsPublish Date: 2/20/2019Review Date: 2/20/2019 -
Comprehensive guidelines, including:
Type: GuidelinesPublish Date: 5/24/2018Review Date: 9/2/2020 -
The goal of this project is to provide an evidence-based online curriculum for health care providers and trainers of health care providers to increase their knowledge on human immunodeficiency viru
Type: Online and Self-Paced LearningPublish Date: 7/13/2017Review Date: 12/29/2019
Archive Resources: 8
-
Quick guide to oral contraceptives and HIV medications drug interactions.
Type: Clinical Reference ToolsPublish Date: 5/3/2017Review Date: 5/3/2017 -
Objectives
- Identify issues associated with treating older individuals with HIV infection
Type: Online and Self-Paced LearningPublish Date: 12/7/2016 -
Objectives
Type: Online and Self-Paced LearningPublish Date: 11/16/2016 -
Objectives
- List available HCV direct acting antivirals (DAAs) available for HCV therapy in 2016
Type: Online and Self-Paced LearningPublish Date: 10/12/2016 -
This toolkit was developed for use for members of the AETC Program and HIV health care professionals to serve as a resource guide on HIV and aging.
Type: Clinical Reference ToolsPublish Date: 4/29/2015 -
AETC HIV and Aging Workgroup
HIV and Aging ToolkitType: Clinical Reference ToolsPublish Date: 4/1/2015 -
Approximately 7/10 people with HIV in the U.S. are not virally suppressed.
Type: Clinical Reference ToolsPublish Date: 1/28/2015 -
Pocket reference with interaction information and patient education recommendations. Order printed copies online from the NY/NJ AETC.
Type: Clinical Reference ToolsPublish Date: 2/1/2014
Articles: 4
-
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain...
-
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted...
-
START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV
The prevailing opinion among experts regarding the optimal CD4 T-cell count at which to start patients on antiretroviral therapy (ART) has shifted several times during the evolution of HIV treatment. These shifts reflect attempts to strike a balance between preventing HIV-associated illness and...
-
Pitavastatin and Darunavir/Ritonavir
Coauthor: Susa Coffey, MD; Medical Editor, AETC National Resource Center
Treatment of dyslipidemia is often complicated by drug interactions between statins and antiretrovirals. Pitavastatin is one of the newer statins approved and is one of the few...
-
Sep 25 (All day)